Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,102,033
-$5,535,577 QoQ
Shares Held
127,450
-17.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#356
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $248,035,659 across 15 Drug Manufacturers - General names. GILD ranks #8 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
346,193 | $44,485,800 | |
| 2 | AMGN |
Amgen Inc
|
97,240 | $35,212,548 | |
| 3 | JNJ |
Johnson & Johnson
|
137,584 | $34,942,208 | |
| 4 | LLY |
ELI LILLY & Co
|
22,773 | $27,314,621 | |
| 5 | ABBV |
AbbVie Inc.
|
87,496 | $22,017,493 | |
| 6 | PFE |
Pfizer Inc
|
873,428 | $21,032,146 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
302,317 | $17,419,505 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
127,450 | $16,102,033 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,102,033 | 127,450 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,637,610 | 155,253 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,960,347 | 162,623 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $18,898,527 | 170,257 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $22,842,656 | 206,031 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $26,884,604 | 239,934 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,836,455 | 225,576 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $21,365,450 | 254,836 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $18,780,752 | 273,732 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $19,228,125 | 262,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $22,214,400 | 274,218 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,736,420 | 316,739 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $24,672,881 | 320,136 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $28,878,040 | 348,054 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $29,876,572 | 348,009 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,873,186 | 322,146 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $18,766,814 | 303,621 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $16,002,037 | 269,168 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $18,101,164 | 249,293 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $16,003,123 | 229,107 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $14,756,629 | 214,299 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $12,021,761 | 186,009 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $10,580,948 | 181,616 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $11,628,476 | 184,024 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $15,613,203 | 202,927 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $17,069,502 | 228,324 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||